Cytokine release syndrome

Results: 7



#Item
1Gene Transfer Safety Assessment Board Adverse Event Report NIH Office of Biotechnology Activities December 2013 Protocol Number: Protocol Title:

Gene Transfer Safety Assessment Board Adverse Event Report NIH Office of Biotechnology Activities December 2013 Protocol Number: Protocol Title:

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-07-21 14:55:58
21  Session IV: Scientific and Commercial Challenges  Review of Selected

1 Session IV: Scientific and Commercial Challenges Review of Selected

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:48:03
31  Session IV: Scientific and Commercial Challenges  Review of Selected

1 Session IV: Scientific and Commercial Challenges Review of Selected

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:17:57
4HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA.  •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. •

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-17 12:59:23
5Arzerra II-27 Final DHPC and communication plan

Arzerra II-27 Final DHPC and communication plan

Add to Reading List

Source URL: www.mhra.gov.uk

Language: English - Date: 2014-07-31 09:55:30
6HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA.  •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. •

Add to Reading List

Source URL: www.gsksource.com

Language: English - Date: 2014-08-21 00:16:10
7ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2014-02-27 10:08:11